GVT (monosodium alpha-luminol)
/ Bach Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
June 16, 2023
Prevention of the development of additional purulent-septic complications in peritonitis of various etiologies, taking into account reduced reactivity
(PubMed, Khirurgiia (Mosk))
- "Aminodihydrophthalazinedione sodium (Galavit) is effective and safe for preventing the development of additional purulent-septic complications associated with a reduced reactivity in patients with peritonitis, decreases the incidence of purulent-septic complications."
Journal • CD4 • NCAM1
December 02, 2022
Alternative medicine in uro-oncology
(PubMed, Urologie)
- "Alternative medicine is pseudo-medicine that may have a positive effect on mental well-being in the short term, but is mostly associated with disadvantages for the patient in the long term."
Journal • Review • Genito-urinary Cancer • Oncology
March 16, 2021
Administration of the immunomodulatory drug aminodihydrophthalazinedione sodium for prevention of progression pneumonia induced COVID-19
(PubMed, Ter Arkh)
- "Aim to determine the efficacy of drug aminodihydrophthalazinedione sodium (Galavit) for prevention of progression of the coronavirus infection pulmonary complications: acceleration of regression of pulmonary infiltrates and resolution of COVID-induced pneumonia...According to the control computer tomography data the stabilization of the pulmonary parenchyma affection degree was noted, as well as reduction of the size of the compacted areas in the pulmonary tissue and formation of the picture of organising pneumonia that contributed to reduction of respiratory failure grade. The use of aminodihydrophthalazinedione sodium in complex therapy of COVID-induced pneumonia has a modulating effect on the immune system, prevents the progression of pulmonary tissue affection, promotes regression of infiltration foci, preventing the development of excessive pneumofibrosis and the progression of respiratory failure."
Journal • Fibrosis • Immune Modulation • Infectious Disease • Inflammation • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
June 06, 2019
Efficiency of immunomodulatotors for complex therapy of chronic recurrent cystitis in women
(PubMed, Urologiia)
- "The use of Galavit in the treatment of women with chronic recurrent bacterial cystitis has pathogenetic basis. A clear advantage of the drug is more rapid relief of symptoms, normalization of laboratory parameters, recovery of chronorhythms and the achievement of clinical remission."
Clinical • Journal
August 18, 2019
Bach Pharma Inc, developing new drug, GVT to treat veterans suffering from Gulf War Illness, and millions of people suffering from neurodegenerative diseases
(PRWeb)
- "Bach Pharma, Inc...is continuing its research and development of its drug platform GVT (Monosodium Luminol), created to treat and cure multiple neurodegenerative diseases including...Parkinson’s disease among others....Bach Pharma is in the midst of a $2.2M capital raise in order to fund the next stage of preclinical testing, specifically a toxicology study for the Veteran’s Administration....Once the toxicology studies are completed, Bach will qualify for an additional $8 million commitment from the US Department of Defense for additional testing of GVT."
Financing • Preclinical
1 to 5
Of
5
Go to page
1